Cellular Biomedicine Group Company Profile (NASDAQ:CBMG)

About Cellular Biomedicine Group

Cellular Biomedicine Group logoCellular Biomedicine Group, Inc. (CBMG) is a biomedicine company. The Company is engaged in the development of treatments for cancerous and degenerative diseases utilizing cell-based technologies. The Company operates in Biomedicine Cell Therapy segment. The Company's technology includes platforms, such as Immune Cell therapy for treatment of broad range of cancers using Vaccine, T Cells Receptor (TCR) clonality analysis technology and T Central Memory Cell (Tcm) preparation methodologies, Chimeric Antigen Receptor T cell (CAR-T), and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases, with primary research and manufacturing facilities in China. It is focused on developing and marketing cell-based therapies based on its cellular platforms, to treat serious chronic and degenerative diseases, such as cancer, orthopedic diseases, including osteoarthritis and tissue damage, various inflammatory diseases and metabolic diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CBMG
  • CUSIP:
Key Metrics:
  • Previous Close: $14.36
  • 50 Day Moving Average: $14.26
  • 200 Day Moving Average: $15.81
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $198.42M
  • Outstanding Shares: 14,102,000
  • Beta: 2.83
Additional Links:
Companies Related to Cellular Biomedicine Group:

Analyst Ratings

Consensus Ratings for Cellular Biomedicine Group (NASDAQ:CBMG) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cellular Biomedicine Group (NASDAQ:CBMG)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Cellular Biomedicine Group (NASDAQ:CBMG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/11/2016        
3/14/2016Q415($0.42)($0.43)$1.50 millionViewN/AView Earnings Details
11/13/2015Q3($0.43)($0.44)ViewN/AView Earnings Details
8/14/2015Q215($0.37)($0.44)ViewN/AView Earnings Details
5/18/2015Q115($0.40)($0.39)ViewN/AView Earnings Details
3/31/2015($0.32)($0.57)ViewN/AView Earnings Details
11/19/2014Q314($0.31)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cellular Biomedicine Group (NASDAQ:CBMG)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Cellular Biomedicine Group (NASDAQ:CBMG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cellular Biomedicine Group (NASDAQ:CBMG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/22/2016Andrew K ChanSVPSell1,307$18.22$23,813.54View SEC Filing  
2/17/2016Andrew K. ChanSVPSell1,516$17.76$26,924.16View SEC Filing  
1/21/2016Andrew K. ChanSVPSell2,812$12.90$36,274.80View SEC Filing  
12/21/2015Andrew K. ChanSVPSell12,812$21.94$281,095.28View SEC Filing  
11/23/2015Andrew K. ChanSVPSell5,332$20.64$110,052.48View SEC Filing  
10/21/2015Wei (William) CaoCEOSell20,000$19.59$391,800.00View SEC Filing  
10/20/2015Andrew K. ChanSVPSell5,215$20.20$105,343.00View SEC Filing  
9/21/2015Andrew K. ChanSVPSell27,927$20.80$580,881.60View SEC Filing  
12/23/2014Pak To LeungMajor ShareholderSell142,857$14.00$1,999,998.00View SEC Filing  
6/26/2014David BolocanDirectorBuy10,000$5.00$50,000.00View SEC Filing  
5/22/2014Tony LiuCFOBuy100,000$5.00$500,000.00View SEC Filing  
7/23/2013Keith WongDirectorSell320,050$0.13$41,606.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cellular Biomedicine Group (NASDAQ:CBMG)
DateHeadline
4-traders.com logoCellular Biomedicine : Announces Dismissal of Class Action Litigation (NASDAQ:CBMG)
www.4-traders.com - August 19 at 11:39 AM
finance.yahoo.com logoCellular Biomedicine Group Announces Dismissal of Class Action Litigation (NASDAQ:CBMG)
finance.yahoo.com - August 18 at 12:31 PM
finance.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Financials (NASDAQ:CBMG)
finance.yahoo.com - August 17 at 4:12 PM
capitalcube.com logoETF’s with exposure to Cellular Biomedicine Group, Inc. : August 17, 2016 (NASDAQ:CBMG)
www.capitalcube.com - August 17 at 4:12 PM
News IconCerebral Palsy Pipeline Market 2016 Global Review Research (NASDAQ:CBMG)
www.fox8live.com - August 16 at 9:22 PM
capitalcube.com logoCellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:CBMG)
www.capitalcube.com - August 15 at 4:17 PM
streetinsider.com logoCellular Biomedicine Group Reports Second Quarter and First Half 2016 Financial Results and Business Highlights (NASDAQ:CBMG)
www.streetinsider.com - August 10 at 11:46 AM
sg.finance.yahoo.com logoCellular Biomedicine reports 2Q loss (NASDAQ:CBMG)
sg.finance.yahoo.com - August 9 at 1:01 PM
finance.yahoo.com logoUPDATE -- Cellular Biomedicine Group Reports Second Quarter and First Half 2016 Financial Results and Business Highlights (NASDAQ:CBMG)
finance.yahoo.com - August 9 at 1:01 PM
finance.yahoo.com logoCellular Biomedicine Group Announces Annual General Meeting of Stockholders (NASDAQ:CBMG)
finance.yahoo.com - August 1 at 8:30 AM
4-traders.com logoCellular Biomedicine : Announces Appointment of New Member to the Board of Directors (NASDAQ:CBMG)
www.4-traders.com - July 13 at 9:30 PM
finance.yahoo.com logoCellular Biomedicine Group Announces Appointment of New Member to the Board of Directors (NASDAQ:CBMG)
finance.yahoo.com - July 12 at 8:30 AM
finance.yahoo.com logo5:27 am Cellular Biomedicine to issue up to 5,137,905 shares of common stock for sale by selling shareholders (NASDAQ:CBMG)
finance.yahoo.com - June 21 at 5:27 AM
capitalcube.com logoETF’s with exposure to Cellular Biomedicine Group, Inc. : June 17, 2016 (NASDAQ:CBMG)
www.capitalcube.com - June 17 at 5:08 PM
News IconSystemic lupus erythematosus pipeline market review 2016 insights shared in detailed report (NASDAQ:CBMG)
www.whatech.com - June 7 at 12:21 PM
4-traders.com logoCELLULAR BIOMEDICINE GROUP, INC. : Shareholder Director Nominations (form 8-K) (NASDAQ:CBMG)
www.4-traders.com - May 25 at 7:18 PM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Shareholder Director Nominations (NASDAQ:CBMG)
biz.yahoo.com - May 25 at 11:02 AM
News IconBiotech Class Action Must Be Amended (NASDAQ:CBMG)
www.courthousenews.com - May 24 at 11:18 AM
capitalcube.com logoETF’s with exposure to Cellular Biomedicine Group, Inc. : May 23, 2016 (NASDAQ:CBMG)
www.capitalcube.com - May 23 at 4:53 PM
capitalcube.com logoCellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 (NASDAQ:CBMG)
www.capitalcube.com - May 23 at 1:25 PM
fxpips.com logoMorning Biggest Movers – LTBR, ATRM, OSUR, SGYP, CBMG, CCXI, OHGI (NASDAQ:CBMG)
www.fxpips.com - May 19 at 10:49 AM
reuters.com logoBRIEF-Cellular Biomedicine reports Q1 results (NASDAQ:CBMG)
www.reuters.com - May 9 at 7:32 PM
4-traders.com logoCellular Biomedicine : Reports First Quarter 2016 Financial Results and Provides Business Highlights (NASDAQ:CBMG)
www.4-traders.com - May 9 at 7:32 PM
sg.finance.yahoo.com logoCellular Biomedicine reports 1Q loss (NASDAQ:CBMG)
sg.finance.yahoo.com - May 9 at 5:18 PM
finance.yahoo.com logoCellular Biomedicine Group Reports First Quarter 2016 Financial Results and Provides Business Highlights (NASDAQ:CBMG)
finance.yahoo.com - May 9 at 4:01 PM
4-traders.com logoCELLULAR BIOMEDICINE GROUP, INC. : Change in Directors or Principal Officers (form 8-K) (NASDAQ:CBMG)
www.4-traders.com - May 5 at 7:58 PM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CBMG)
biz.yahoo.com - May 5 at 12:21 PM
thestreet.com logoRSI Alert: Cellular Biomedicine Group (CBMG) Now Oversold (NASDAQ:CBMG)
www.thestreet.com - May 4 at 7:39 PM
4-traders.com logoCELLULAR BIOMEDICINE GROUP, INC. : Unregistered Sale of Equity Securities, Other Events (form 8-K) (NASDAQ:CBMG)
www.4-traders.com - April 20 at 7:56 PM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events (NASDAQ:CBMG)
biz.yahoo.com - April 20 at 5:14 PM
streetinsider.com logoDangdai International Makes $43.1M Strategic Investment in Cellular Biomedicine Group (CBMG) (NASDAQ:CBMG)
www.streetinsider.com - April 19 at 8:13 PM
finance.yahoo.com logoCellular Biomedicine Group Announces Closing of $43.13 Million Strategic Investment from Dangdai International Group Co., Limited, a Wholly-Owned Hong Kong Subsidiary of Wuhan Dangdai Science & Technology Industries Group Inc. (NASDAQ:CBMG)
finance.yahoo.com - April 19 at 8:30 AM
capitalcube.com logoETF’s with exposure to Cellular Biomedicine Group, Inc. : March 23, 2016 (NASDAQ:CBMG)
www.capitalcube.com - March 23 at 3:09 PM
capitalcube.com logoCellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q4, 2015 By the Numbers (NASDAQ:CBMG)
www.capitalcube.com - March 21 at 1:16 PM
capitalcube.com logoCellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:CBMG)
www.capitalcube.com - March 21 at 10:46 AM
finance.yahoo.com logoCellular Biomedicine Group Reports Full-Year 2015 Financial Results and Recent Operational Progress (NASDAQ:CBMG)
finance.yahoo.com - March 14 at 7:00 AM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 10-K, Annual Report (NASDAQ:CBMG)
biz.yahoo.com - March 14 at 6:08 AM
finance.yahoo.com logoCellular Biomedicine Group Inc. (CBMG) (NASDAQ:CBMG)
finance.yahoo.com - February 21 at 10:24 AM
ft.com logoFundraisings highlight the rise in Chinese pharma R&D (NASDAQ:CBMG)
www.ft.com - February 18 at 5:49 PM
News IconDangdai Invests Over US$43 Million In CBMG (NASDAQ:CBMG)
www.asianscientist.com - February 12 at 10:24 AM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial (NASDAQ:CBMG)
biz.yahoo.com - February 10 at 5:17 PM
nasdaq.com logoSCLN Settles FCPA Charges, OGXI On Cost Discipline Mode, Shire To Face FDA (NASDAQ:CBMG)
www.nasdaq.com - February 5 at 10:00 AM
streetinsider.com logoCellular Biomedicine Group (CBMG) Receives $43M Strategic Investment From Dangdai International (NASDAQ:CBMG)
www.streetinsider.com - February 5 at 10:00 AM
feeds.benzinga.com logoCellular Biomedicine's Stock Surges After Company Receives Strategic Investment (NASDAQ:CBMG)
feeds.benzinga.com - February 4 at 4:50 PM
nasdaq.com logoCellular Biomedicine Group Announces a $43.13 Million Strategic (NASDAQ:CBMG)
www.nasdaq.com - February 4 at 9:56 AM
finance.yahoo.com logoCellular Biomedicine Group Announces a $43.13 Million Strategic Investment From Dangdai International Group Co., Limited, a Wholly Owned Hong Kong Subsidiary of Wuhan Dangdai Science & Technology Industries Group Inc. (NASDAQ:CBMG)
finance.yahoo.com - February 4 at 9:09 AM
seekingalpha.com logoNew chief at Cellular Biomedicine (NASDAQ:CBMG)
seekingalpha.com - January 28 at 9:57 PM
feeds.benzinga.com logoCellular Biomedicine Group Names Tony Liu as CEO (NASDAQ:CBMG)
feeds.benzinga.com - January 28 at 7:54 AM
finance.yahoo.com logoCellular Biomedicine Group Announces Chairman of the Board of Directors, and Appointment of Chief Executive Officer (NASDAQ:CBMG)
finance.yahoo.com - January 28 at 6:00 AM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme (NASDAQ:CBMG)
biz.yahoo.com - November 16 at 9:38 AM

Social

Cellular Biomedicine Group (NASDAQ:CBMG) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff